Medtronic ( MDT 2.27%) and Johnson & Johnson ( JNJ 1.64%) are two very healthy, high-yielding dividend stocks. This makes ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...

Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...

The revenue miss came as sales at Medtronic's Medical Surgical division declined 1.9% to $2.07 billion. The company pointed ...

Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $93.00.